Stockreport

Ginkgo Bioworks Holdings Inc (DNA) Q3 2024 Earnings Call Highlights: Strategic Restructuring ... [Yahoo! Finance]

Ginkgo Bioworks Holdings, Inc.  (DNA) 
PDF R&D Expense: Decreased from $108 million in Q3 2023 to $74 million in Q3 2024. G&A Expense: Decreased from $49 million in Q3 2023 to $42 million in Q3 2024. Adjuste [Read more]